Speaker illustration

undefined undefined undefined

Ask the expert: practical discussions on heart failure management with SGLT2 inhibitors

Event: ESC Congress 2025

Topic: Chronic Heart Failure

Session: Ask the expert: practical discussions on heart failure management with SGLT2 inhibitors

Thumbnail

Ask the expert: practical discussions on heart failure management with SGLT2 inhibitors

Event: ESC Congress 2025

Topic: Chronic Heart Failure

Session: Ask the expert: practical discussions on heart failure management with SGLT2 inhibitors

Thumbnail

HFmrEF/HFpEF across the spectrum: a case-based workshop​

Event: ESC Congress 2025

Topic: Chronic Heart Failure

Session: Fine-tuning patient care: a case-based exploration of finerenone in heart and kidney disease

Thumbnail

Use and timing of guideline-directed medical therapy before and after hospitalization for heart failure: from the EMPACE study

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Vericiguat, SGLT2 inhibitors and implementation

Thumbnail

Optimising treatment for high-risk patients: lessons from VICTORIA

Event: Heart Failure 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation

Thumbnail

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: the VELOCITY study

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease

Thumbnail

Cardiorenal pathways and characteristics of patients with coexisting heart failure and chronic kidney disease (The CaRe Study)

Event: Heart Failure 2025

Topic: Comorbidities

Session: Cardiometabolic and multisystem interactions in heart failure

Thumbnail

Ask the expert: how to optimise care for your patients with heart failure using SGLT2 inhibitors

Event: Heart Failure 2025

Topic: Chronic Heart Failure

Session: Ask the expert: how to optimise care for your patients with heart failure using SGLT2 inhibitors

Thumbnail

Shaping the future: the power of action today

Event: Heart Failure 2025

Topic: Chronic Heart Failure

Session: The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital

Thumbnail

Clinical and financial implications of inpatient and outpatient management strategies for worsening heart failure

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Contemporary epidemiology of worsening heart failure

Thumbnail

ESC 365 is supported by